Is LifeMD, Inc. (LFMD) a Buy, Sell, or Hold?
LifeMD, Inc.
NASDAQ:LFMD
$4.51 USD
-$0.25 (-5.25%)
- Volume
- 550.38K
- Average Volume
- 1.08M
- Market Capitalization
- $218.11M
- P/E Ratio
- -10.94
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $12.72
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $-0.19
- Current Ratio
- $1.04
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Justin Schreiber |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Current Symbol | LFMD |
| CUSIP | 53216B104 |
| CIK | 0000948320 |
| Web | https://www.lifemd.com |
| Phone | 866 351 5907 |
| Currency | USD |
| Employees | 389 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.41 |
| Payout Ratio | -0.19 |
| Current Ratio | 1.04 |
| Quick Ratio | 0.98 |
| Cash Ratio | 0.70 |
Sales & Book Value
| Annual Sales | $194.06M |
| Price / Sales | 0.99 |
| Cash Flow | 0.31 |
| Price / Cash Flow | 14.71 |
| Price / Book | 14.20 |
Price Target and Rating
| Average Stock Price Forecast | $10.00 |
| High Stock Price Forecast | $10.00 |
| Low Stock Price Forecast | $10.00 |
| Forecast Upside/Downside | -54.90% |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 10 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.23 |
| Trailing P/E Ratio | -10.94 |
| PEG Ratio | 0.10 |
| P/E Growth | 0.10 |
| Net Income | $-7.11M |
| Net Margin | -7.41% |
| Pretax Margin | -6.79% |
| Return on Equity | -172.30% |
| Return on Assets | -23.17% |
Financials Score
| AltmanZ Score | 0.13 |
| Piotroski Score | 4.00 |
| Working Capital | 2.11M |
| Total Assets | 70.12M |
| Ebit | -13.98M |
| Market Cap | 218.11M |
| Total Liabilities | 55.09M |
Poll Results
About LifeMD, Inc. (NASDAQ:LFMD) Stock
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array ... of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
2026-06-23 08:00:00
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.
2026-06-22 08:00:00
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states
LifeMD Appoints Umesh Sripad as Chief Technology Officer
2026-06-01 08:05:00
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Umesh Sripad as Chief Technology Officer (CTO), effective immediately. In this role, Mr. Sripad will lead LifeMD's technology strategy, platform transformation, AI enablement, cybersecurity, data infrastructure, and enterprise scalability initiatives as the company continues its rapid expansion.
LifeMD Appoints Umesh Sripad as Chief Technology Officer
2026-06-01 08:05:00
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth
LifeMD to Participate in Upcoming Investor Conferences
2026-05-15 08:00:00
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences.
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
2026-05-06 23:01:15
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
2026-05-06 19:35:41
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.01 per share a year ago.
LifeMD Reports First Quarter 2026 Results
2026-05-06 16:05:00
First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company's guidance. Gross margin increased approximately 420 basis points to 88%, versus the first quarter of 2025, reflecting favorable revenue mix and lower fulfillment costs.
Frequently Asked Questions
-
What is the current LifeMD, Inc. (LFMD) stock price?
-
LifeMD, Inc.(NASDAQ:LFMD) stock price is $4.51 in the last trading session. During the trading session, LFMD stock reached the peak price of $12.72 while $2.56 was the lowest point it dropped to. The percentage change in LFMD stock occurred in the recent session was --5.25% while the dollar amount for the price change in LFMD stock was -$-0.25.
-
LFMD's industry and sector of operation?
-
The NASDAQ listed LFMD is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of LFMD?
-
Shane Biffar | Chief Compliance Officer & Deputy General Counsel
Eric H. Yecies | Chief Legal Officer, General Counsel & Corporate Secretary
Umesh Sripad | Chief Technology Officer
Nicholas Alvarez | Chief Acquisition Officer & Head of Customer Acquisition
Stefan Galluppi | Chief Innovation Officer -
How many employees does LFMD have?
-
Number of LFMD employees currently stands at 389. LFMD operates from 236 Fifth Avenue, New York City, NY 10001, US.
-
Link for LFMD official website?
-
Official Website of LFMD is: https://www.lifemd.com
-
How do I contact LFMD?
-
LFMD could be contacted at phone #866 351 5907 and can also be accessed through its website. LFMD operates from 236 Fifth Avenue, New York City, NY 10001, US.
-
How many shares of LFMD are traded daily?
-
The average number of LFMD shares traded daily for last 3 months was 1.08M.
-
What is the market cap of LFMD currently?
-
The market value of LFMD currently stands at $218.11M with its latest stock price at $4.51